Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial. 2007

Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
The Department of Surgery, Washington University, St Louis, MO 63110, USA. shenoysu@msnotes.wustl.edu

This pilot trial was designed to assess the safety and efficacy of SRL in liver transplant recipients with renal dysfunction. Forty patients with renal dysfunction (24-hr CrCl 40-80 mL/min) were randomized to be withdrawn from the calcineurin inhibitor (CNI) and receive sirolimus (SRL) or to continue CNI (control arm). Improvement in 24-hour CrCl was seen in the SRL arm at 3 months (75 mL/min SRL vs. 56 mL/min control, P=0.012), whereas at 12 months there was a trend toward improvement in the SRL arm (72 mL/min SRL vs. 58 mL/min control, P=0.09). Two patients, one in each arm, developed steroid-sensitive rejection. Side effects of SRL were limited and included hyperlipidemia requiring treatment (15%), pruritus (5%), and mouth sores (25%). In this trial, SRL-based immunosuppression was a safe alternative to CNI. Although early improvements were observed, withdrawing CNI and replacing it with SRL did not result in a statistically significant improvement in renal function at 12 months of follow-up.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
August 2010, Artificial organs,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
September 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
July 2013, Iranian journal of kidney diseases,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
September 2010, Transplantation proceedings,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
March 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
October 2011, Transplantation,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
September 2012, Pediatric transplantation,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
December 2006, Transplantation,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
December 2010, Transplantation proceedings,
Surendra Shenoy, and Karen L Hardinger, and Jeffrey Crippin, and Niraj Desai, and Kevin Korenblat, and Mauricio Lisker-Melman, and Jeffrey A Lowell, and William Chapman
December 2006, Transplantation proceedings,
Copied contents to your clipboard!